Co-Diagnostics Begins Clinical Testing for Respiratory Multiplex PCR Test
The company aims to support FDA 510(k) clearance submission for its point-of-care platform detecting flu A/B, COVID-19, and RSV.
The company aims to support FDA 510(k) clearance submission for its point-of-care platform detecting flu A/B, COVID-19, and RSV.
Two investigational diagnostics demonstrate significantly higher sensitivity than current CDC-recommended two-tier testing in Journal of Clinical Microbiology studies.
The clinical diagnostics expert discusses new tools, persistent challenges, and why keeping patients front of mind matters more than ever.
Quest Diagnostics has launched a new PCR-based diagnostic test for the Oropouche virus, enhancing preparedness for this emerging disease.
electronRx announced it will launch purpleDx, a smartphone app for cardiopulmonary assessment, at CES 2025.
QuidelOrtho and BÜHLMANN Laboratories have partnered to launch the fCAL turbo and fPELA turbo fecal biomarker assays on VITROS Systems.
Linear Diagnostics has secured funding to finalize and clinically validate a rapid, accurate STI diagnostic platform.